Market Place
Sourcing Support
All News #Library
Biotech
Keros Pharma Partners With Sean M. Healey & AMG Center For ALS
09 Mar 2026 //
GLOBENEWSWIRE
Keros Therapeutics To Present At Healthcare Conferences
18 Feb 2026 //
GLOBENEWSWIRE
Keros Therapeutics Doses First Patient in Phase 3 RENEW trial
18 Jul 2025 //
GLOBENEWSWIRE
Keros Therapeutics Announces TROPOS Topline Data & Restructuring
29 May 2025 //
GLOBENEWSWIRE
Keros Therapeutics Reports Phase 1 Results of KER-065 Trial
31 Mar 2025 //
GLOBENEWSWIRE
Keros Therapeutics to Present at Guggenheim Biotech Conference
30 Jan 2025 //
GLOBENEWSWIRE
Keros, Takeda Partner To Advance Elritercept With Global License
21 Jan 2025 //
GLOBENEWSWIRE
Keros shares collapse on ‘unanticipated’ setback for lung drug
12 Dec 2024 //
BIOPHARMADIVE
Takeda Puts Up to $1.3B for Keros’ Blood Cancer Anemia Drug
04 Dec 2024 //
PRESS RELEASE
Keros Signs Global License Deal with Takeda for Elritercept
03 Dec 2024 //
GLOBENEWSWIRE
Keros Therapeutics Updates Cantor Conference Presentation Time
12 Sep 2024 //
GLOBENEWSWIRE
Keros Presents Preclinical and Clinical Data from its KER-012 Program
22 May 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.